EURONEXT:BETR
A Better Life Pharma
- Stock
Last Close
0.10
24/09 20:00
Market Cap
14.69M
Beta: 1.42
Volume Today
7K
Avg: 160.13K
PE Ratio
−4.23
PFCF: −4.62
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jan '14 | Jan '15 | Jan '16 | Jan '17 | Jan '18 | Jan '19 | Jan '20 | Jan '21 | Jan '22 | Jan '23 | Jan '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -4.75K - | -2.69K 43.43% | -63 97.66% | |||||||||
average payables | 59.98K - | 43.88K 26.84% | 303.99K 592.76% | 930.95K 206.25% | 787.58K 15.40% | 468.17K 40.56% | 778.82K 66.35% | 2.70M 246.25% | 3.92M 45.45% | 4.39M 11.89% | 2.72M 38.07% | |
average receivables | 4.75K - | 2.69K 43.43% | 63 97.66% | 22.24K - | 90.93K 308.77% | 328.74K 261.54% | 422.56K 28.54% | 171.09K 59.51% | 28.37K 83.42% | |||
book value per share | -0.16 - | -0.06 61.48% | -0.06 1.16% | -0.26 333.55% | -0.01 97.27% | 0.39 5,652.36% | 0.18 54.59% | -0.17 196.59% | -0.05 69.87% | -0.12 141.02% | -0.10 20.20% | |
capex per share | -0.09 - | -0.04 61.84% | -0.00 90.10% | |||||||||
capex to depreciation | -0.95 - | -0.39 59.31% | -0.28 26.89% | |||||||||
capex to operating cash flow | 0.17 - | 0.07 59.83% | 0.01 80.42% | |||||||||
capex to revenue | -11.22 - | 2.39 121.34% | ||||||||||
cash per share | 0.00 - | 0.00 325.44% | 0.01 1,300.72% | 0.02 51.82% | 0.01 49.08% | 0.01 16.75% | 0.18 2,050.76% | 0.01 96.79% | 0.00 59.84% | 0.00 95.83% | 0.00 256.45% | |
days of inventory on hand | ||||||||||||
days payables outstanding | 826.06 - | |||||||||||
days sales outstanding | 1.04K - | -4.70K 553.92% | 0.00 100.00% | |||||||||
debt to assets | 47.74 - | 2.07 - | 0.52 74.72% | 0.41 22.37% | 0.57 40.07% | 0.37 34.35% | 1.20 221.22% | 15.89 1,221.95% | 0.76 95.25% | |||
debt to equity | -0.46 - | -0.19 - | -4.43 2,276.42% | 1.00 122.48% | 1.77 77.62% | -0.11 106.12% | -0.36 231.76% | -0.11 69.23% | -0.02 79.50% | |||
dividend yield | ||||||||||||
earnings yield | -0.20 - | -1.37 585.52% | -0.12 91.05% | -0.78 533.50% | -0.00 99.90% | -0.44 57,883.06% | -0.94 115.87% | -0.87 7.60% | -0.78 10.59% | -0.71 9.00% | -0.35 50.31% | |
enterprise value | 4.11M - | 730.43K 82.24% | 97.63M 13,266.75% | 10.80M 88.94% | 198.39M 1,737.13% | 24.34M 87.73% | 23.28M 4.36% | 42.02M 80.52% | 16.81M 59.99% | 13.94M 17.07% | 8.40M 39.76% | |
enterprise value over ebitda | -90.56 - | -10.23 88.71% | -8.14 20.38% | -1.40 82.84% | -156.41 11,096.19% | -4.35 97.22% | -3.01 30.91% | -5.36 78.30% | -1.51 71.88% | -1.51 0.01% | -2.62 73.51% | |
ev to operating cash flow | -150.75 - | -13.87 90.80% | -426.07 2,971.97% | -21.81 94.88% | -406.48 1,763.47% | -4.89 98.80% | -2.95 39.59% | -5.86 98.56% | -1.50 74.41% | -9.27 517.93% | -3.40 63.37% | |
ev to sales | 481.08 - | -1.04K 316.42% | 0.00 100.00% | |||||||||
free cash flow per share | -0.01 - | -0.05 703.72% | -0.03 35.06% | -0.07 122.93% | -0.06 7.07% | -0.65 958.24% | -0.56 13.34% | -0.27 52.04% | -0.15 44.75% | -0.02 88.30% | -0.02 30.25% | |
free cash flow yield | -0.01 - | -0.07 895.30% | -0.00 96.74% | -0.05 1,894.66% | -0.00 94.74% | -0.28 11,223.12% | -0.40 42.14% | -0.17 56.03% | -0.72 312.36% | -0.12 83.61% | -0.30 156.22% | |
graham net net | -0.16 - | -0.06 61.45% | -0.07 8.40% | -0.26 297.81% | -0.06 78.35% | -0.55 880.05% | -0.19 66.14% | -0.20 7.01% | -0.06 69.35% | -0.09 43.03% | -0.07 16.97% | |
graham number | 0.74 - | 1.08 46.02% | 1.43 32.83% | 2.51 75.20% | 0.05 97.84% | 2.98 5,385.28% | 2.30 22.69% | 2.27 1.34% | 0.43 81.00% | 0.54 25.12% | 0.24 55.10% | |
income quality | 0.04 - | 0.05 45.19% | 0.02 63.62% | 0.06 214.87% | 3.26 5,325.17% | 0.54 83.33% | 0.40 26.08% | 0.20 51.01% | 0.92 367.44% | 0.16 82.59% | 0.86 433.49% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0.61 Infinity% | 0.97 58.95% | 0.10 90.01% | 0 100% | 0 | 0 | 0 | |
interest coverage | -0.78 - | -0.58 25.72% | -516.56 - | -38.31 92.58% | -7.59 80.20% | -43.69 475.74% | -197.39 351.85% | -174.96 11.37% | -140.83 19.51% | -63.07 55.22% | ||
interest debt per share | 0.09 - | 0.19 112.49% | 0.05 - | 0.04 29.24% | 0.49 1,282.05% | 0.34 30.04% | 0.02 94.14% | 0.02 3.59% | 0.01 24.79% | 0.00 81.30% | ||
inventory turnover | ||||||||||||
invested capital | -0.46 - | -0.19 - | -4.43 2,276.42% | 1.00 122.48% | 1.77 77.62% | -0.11 106.12% | -0.36 231.76% | -0.11 69.23% | -0.02 79.50% | |||
market cap | 3.77M - | 731.50K 80.60% | 97.73M 13,260.94% | 10.59M 89.17% | 198.22M 1,772.51% | 20.91M 89.45% | 21.25M 1.63% | 41.67M 96.06% | 15.59M 62.59% | 12.76M 18.13% | 8.19M 35.82% | |
net current asset value | -751.38K - | -69.86K 90.70% | -463.90K 564.04% | -1.94M 317.29% | -345.38K 82.16% | -4.84M 1,302.63% | -2.11M 56.37% | -4.62M 118.53% | -3.90M 15.58% | -7.53M 93.20% | -7.70M 2.15% | |
net debt to ebitda | -7.51 - | 0.01 100.20% | 0.01 44.10% | -0.03 430.06% | -0.13 382.27% | -0.61 360.66% | -0.26 57.35% | -0.04 83.12% | -0.11 148.73% | -0.13 16.32% | -0.06 49.22% | |
net income per share | -0.16 - | -0.86 453.57% | -1.54 78.52% | -1.09 29.20% | -0.02 98.29% | -1.01 5,319.01% | -1.33 31.61% | -1.34 0.78% | -0.16 88.02% | -0.10 35.05% | -0.03 74.74% | |
operating cash flow per share | -0.01 - | -0.05 703.72% | -0.03 35.06% | -0.07 122.93% | -0.06 7.07% | -0.55 803.38% | -0.52 5.02% | -0.27 49.42% | -0.15 44.01% | -0.02 88.30% | -0.02 30.25% | |
payables turnover | 0.44 - | |||||||||||
receivables turnover | 0.35 - | -0.08 122.03% | 82.87K 106,803,803.41% | |||||||||
research and ddevelopement to revenue | 1.32 - | -7.05 635.24% | 0.00 100.00% | |||||||||
return on tangible assets | -105.19 - | -622.69 491.98% | -80.84 87.02% | -47.33 41.46% | -0.81 98.28% | -37.17 4,478.63% | -2.69 92.75% | -27.20 909.83% | -10.47 61.51% | -121.22 1,057.83% | -8.90 92.66% | |
revenue per share | 0.00 - | -0.00 146.41% | 356.87 23,899,210.41% | |||||||||
roe | 1.00 - | 14.44 1,337.24% | 26.08 80.62% | 4.26 83.67% | 2.67 37.30% | -2.61 197.60% | -7.55 189.84% | 7.88 204.34% | 3.13 60.25% | 0.84 73.05% | 0.27 68.34% | |
roic | 0.21 - | 2.31 983.68% | 26.12 1,032.66% | 4.93 81.12% | -7.77 257.55% | -0.83 89.35% | -1.59 92.32% | 1.92 220.99% | 7.38 283.57% | 1.08 85.32% | 0.30 72.06% | |
sales general and administrative to revenue | 158.00 - | -182.69 215.62% | 0.00 100.00% | |||||||||
shareholders equity per share | -0.16 - | -0.06 61.48% | -0.06 1.16% | -0.26 333.55% | -0.01 97.27% | 0.39 5,652.36% | 0.18 54.59% | -0.17 196.59% | -0.05 69.87% | -0.12 141.02% | -0.10 20.20% | |
stock based compensation to revenue | 33.02 - | -20.48 162.03% | 0.00 100.00% | |||||||||
tangible asset value | -750.51K - | -69.44K 90.75% | -459.85K 562.19% | -1.93M 320.14% | -345.38K 82.12% | -4.84M 1,301.43% | 1.86M 138.34% | -4.61M 348.57% | -3.88M 15.86% | -7.53M 94.12% | -7.70M 2.15% | |
tangible book value per share | -0.16 - | -0.06 61.48% | -0.06 1.16% | -0.26 333.55% | -0.04 83.15% | -0.54 1,141.35% | 0.12 123.00% | -0.17 238.29% | -0.05 69.87% | -0.09 69.25% | -0.07 19.09% | |
working capital | -722.62K - | -69.86K 90.33% | -463.90K 564.04% | -1.94M 317.29% | -345.38K 82.16% | -4.84M 1,302.63% | 2.52M 152.03% | -4.52M 279.23% | -3.00M 33.59% | -7.07M 135.74% | -6.50M 8.07% |
All numbers in USD (except ratios and percentages)